Europe Probiotics Market size was valued at USD 10,863.80 million in 2018 and grew to USD 18,798.61 million in 2024. The market is anticipated to reach USD 39,914.09 million by 2032, expanding at a CAGR of 9.8% during the forecast period.
REPORT ATTRIBUTE
DETAILS
Historical Period
2020-2023
Base Year
2024
Forecast Period
2025-2032
Europe Probiotics Market Size 2024
USD 18,798.61 million
Europe Probiotics Market, CAGR
9.8%
Europe Probiotics Market Size 2032
USD 39,914.09 million
The Europe probiotics market is led by global and regional players such as Novozymes A/S, BioGaia, Nestlé S.A., Danone S.A., Yakult Honsha Co., Ltd., DSM-Firmenich, Kerry Group, Lallemand Inc., Adisseo, Probi, Chr. Hansen A/S, and International Flavors & Fragrances Inc. These companies drive growth through strong product portfolios, advanced strain research, and wide retail networks. Western Europe dominates with over 45% market share in 2024, supported by high consumer awareness, established dairy traditions, and regulatory backing. Southern Europe follows with around 20%, while Northern and Eastern Europe collectively account for over 30%, highlighting rising demand across diverse regions.
Market Insights
The Europe probiotics market was valued at USD 10,863.80 million in 2018, grew to USD 18,798.61 million in 2024, and is projected to reach USD 39,914.09 million by 2032, at a CAGR of 9.8%.
Strong demand for preventive healthcare and digestive health products drives growth, with probiotic dairy foods dominating at over 70% share in 2024 due to widespread consumer acceptance and clinical validation of strains.
Emerging non-dairy and plant-based probiotics, digital retail expansion, and functional beverages present key trends, offering opportunities to diversify product formats and reach wider demographics.
The competitive landscape is led by Novozymes, BioGaia, Nestlé, Danone, Yakult, DSM-Firmenich, Kerry Group, Lallemand, Adisseo, Probi, and Chr. Hansen, focusing on innovation, partnerships, and clinical-backed product launches.
Western Europe held 45% share in 2024, followed by Southern Europe (20%), Northern Europe (18%), Eastern Europe (12%), and Central Europe (5%), highlighting strong regional adoption patterns.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
Probiotic food and beverages dominated the Europe probiotics market in 2024, accounting for over 70% share. Within this category, dairy products such as yogurt and fermented milk lead due to strong consumer acceptance, widespread availability, and perceived health benefits in digestive wellness. Rising demand for functional foods and increasing awareness of gut microbiota support the growth of cereals, baked foods, and fermented meat, though these remain niche compared to dairy. Probiotic dietary supplements continue to grow in infant formula and adult nutrition, while animal feed adoption is driven by reduced antibiotic use in livestock.
For instance, Danone’s Actimel contains the proprietary bacteria Lacticaseibacillus paracasei subspecies paracasei CNCM I-1518, which is also known as L. casei Danone. Each bottle is guaranteed to contain at least 20 billion of these cultures at the time of consumption. The product, which also includes vitamins D and B6, is marketed to support the normal function of the immune system.
By Ingredient
Bacteria-based probiotics held the largest market share, exceeding 85% in 2024, driven by the widespread use of Lactobacillus and Bifidobacterium strains in both food products and supplements. These strains are well-studied for their effectiveness in improving gut health, immunity, and reducing digestive disorders, making them a preferred choice for manufacturers. Streptococcus species add value in fermented dairy production, while yeast-based probiotics like Saccharomyces are expanding in dietary supplements due to their resilience and role in managing gastrointestinal conditions. The dominance of bacteria remains strong due to regulatory support and clinical validation.
For instance, Arla Foods’ infant formula, such as Baby&Me® 5HMO-Lacprotec, incorporates the well-researched probiotic strain Bifidobacterium animalis subsp. lactis BB-12 to support infant digestive development.
By End User
Human probiotics led the Europe market with more than 80% share in 2024, supported by rising demand among adults for digestive health, immunity enhancement, and preventive nutrition. The adult segment dominates due to higher supplement intake, regular consumption of probiotic-rich foods, and strong marketing by functional food brands. Probiotics for children are steadily expanding, fueled by growing demand for infant formula enriched with beneficial strains. Meanwhile, animal probiotics show significant growth potential, particularly in livestock and poultry, as producers seek alternatives to antibiotics to enhance feed efficiency, gut health, and overall productivity.
Key Growth Drivers
Rising Health Awareness and Preventive Nutrition
The growing focus on preventive healthcare has fueled the adoption of probiotics across Europe. Consumers increasingly seek functional foods and supplements that support immunity, digestion, and overall well-being, creating sustained demand. The rising prevalence of lifestyle-related diseases and digestive disorders has strengthened the shift toward probiotics as part of daily diets. Dairy-based products such as yogurt and fermented milk remain the most preferred formats, aligning with consumer taste and convenience. Public health campaigns and endorsements from medical professionals further highlight the importance of gut microbiota balance. As a result, both retail and online sales of probiotic-enriched products are expanding rapidly, with younger consumers and urban populations driving higher adoption.
For instance, Danone’s Actimel probiotic drink contains ≥1×10⁸ CFU/ml of Lactobacillus casei DN-114 001, marketed across Europe as an immune-support beverage.
Innovation in Probiotic Food and Beverages
Continuous innovation in food and beverage formats has been a critical growth driver for the probiotics industry in Europe. Manufacturers are introducing probiotics into cereals, baked foods, beverages, and even snacks to cater to diverse consumption patterns. Dairy products continue to dominate, but non-dairy categories are rising due to lactose intolerance and vegan trends. Companies are investing in strain-specific research to enhance product efficacy, stability, and taste. Clean-label demand and plant-based alternatives also push brands to innovate with probiotic fortification while meeting natural ingredient expectations. Packaging advancements that preserve probiotic viability are expanding retail shelf life and boosting consumer confidence. The wide range of formats has widened consumer access, making probiotics a mainstream part of European diets.
For instance, Valio has launched lactose-free probiotic yogurts fortified with the LGG strain, serving both health-conscious and lactose-intolerant consumers. The specific concentration of LGG bacteria can vary by product. For example, some Valio yogurts contain 5×107 CFU/g, while some drinking yogurts contain a higher count per serving.
Government upport and Regulatory Backing
Supportive regulatory frameworks and government health initiatives are driving the European probiotics market. Countries such as Germany, France, and the U.K. have adopted stricter antibiotic reduction policies in livestock, boosting demand for animal probiotics. On the human side, the European Food Safety Authority (EFSA) has provided scientific assessments that encourage consumer confidence in specific probiotic strains. Subsidies and investments in gut health research further strengthen industry growth. Rising healthcare costs have also led policymakers to promote preventive nutrition, creating favorable conditions for probiotics. The alignment of probiotic adoption with broader health goals, such as lowering the burden of gastrointestinal diseases, has enhanced credibility and long-term acceptance. These regulatory and policy-driven initiatives are ensuring steady expansion across both dietary supplements and food applications.
Key Trends & Opportunities
Shift Toward Non-Dairy and Plant-Based Formats
While dairy dominates, non-dairy probiotic food and beverages are gaining momentum across Europe. The growing number of lactose-intolerant and vegan consumers is driving demand for plant-based probiotic solutions in cereals, juices, and snacks. Functional drinks fortified with probiotics, particularly in sports nutrition and wellness beverages, are expanding at a rapid pace. This shift offers significant opportunities for innovation and portfolio diversification. Manufacturers are also leveraging advanced encapsulation technologies to maintain probiotic stability in non-dairy formats, ensuring effectiveness. The trend is reshaping consumer perception of probiotics as versatile and accessible beyond traditional yogurt products.
For instance, Biomel’s almond-based probiotic drinks deliver 1 billion CFU of Bifidobacterium and Lactobacillus strains per serving, marketed in the U.K. as dairy-free functional beverages.
Digital Marketing and E-commerce Growth
The expansion of e-commerce platforms has transformed probiotic sales in Europe. Consumers increasingly prefer online purchases for supplements and specialty foods due to convenience, wider availability, and personalized recommendations. Digital marketing campaigns highlighting gut health benefits and product differentiation are significantly influencing purchasing behavior. Subscription-based models for probiotic supplements are gaining traction, providing steady revenue streams for manufacturers. Social media awareness campaigns and endorsements from nutritionists are expanding product reach across diverse demographics. This growing digital shift presents a strong opportunity for companies to directly connect with consumers and reinforce brand loyalty.
Key Challenges
Strict Regulatory Approvals and Health Claims
Despite overall support, regulatory challenges remain a barrier to faster growth in the European probiotics market. The EFSA maintains strict guidelines for health claims, often requiring extensive scientific evidence that many companies find costly and time-consuming. Products making unapproved claims can face rejections or removal from shelves, limiting brand credibility. Smaller firms often struggle with compliance costs, slowing product innovation and launches. This regulatory complexity creates an uneven playing field, where only well-funded companies can consistently navigate approval requirements. As a result, market entry for new strains and applications is slower than in regions with more flexible frameworks.
High Production Costs and Shelf-Life Concerns
Probiotic production requires advanced fermentation, encapsulation, and cold-chain logistics to maintain viability, which raises costs significantly. Many probiotics are sensitive to temperature and storage conditions, limiting distribution in regions with less developed infrastructure. Shelf-life stability remains a challenge, particularly in non-dairy and ready-to-drink formats, where ensuring strain survival until consumption is critical. These cost and stability concerns reduce affordability and accessibility, restricting wider adoption across price-sensitive consumers. For manufacturers, the balance between innovation and cost-efficiency is difficult to achieve. This continues to pose a barrier to scaling probiotics beyond premium markets and achieving broader penetration.
Regional Analysis
Western Europe
Western Europe dominated the probiotics market in 2024, holding over 45% share. Countries such as Germany, France, and the U.K. lead due to high consumer awareness, strong retail infrastructure, and widespread use of probiotic-enriched dairy products. Germany is a hub for probiotic research and innovation, while France demonstrates high adoption in both supplements and functional foods. The U.K. market benefits from growing preventive healthcare awareness and increasing demand for gut health products. With premium product positioning and robust regulatory compliance, Western Europe continues to drive innovation and sustain leadership across both human and animal probiotic segments.
Southern Europe
Southern Europe accounted for around 20% of the market share in 2024, with Italy and Spain as key contributors. Probiotic-rich dairy consumption is deeply rooted in Mediterranean diets, boosting demand in yogurt, cheese, and fermented milk products. Italy shows rising adoption of probiotic supplements in adult and infant nutrition, supported by healthcare practitioner recommendations. Spain leads in functional beverages and fortified foods, reflecting increasing consumer interest in digestive health. Growing investments in preventive nutrition and wellness tourism also expand opportunities. Southern Europe’s balance of traditional dietary habits and new product innovations supports steady growth in this region.
Northern Europe
Northern Europe represented nearly 18% of the market share in 2024, driven by strong adoption in Scandinavia and the Baltic states. High consumer trust in scientifically validated products has spurred demand for dietary supplements and probiotic-enriched dairy alternatives. Countries such as Sweden and Denmark showcase rising consumption of plant-based probiotic beverages, aligned with sustainability and vegan trends. Preventive healthcare initiatives across the region encourage probiotic use in both adult and child nutrition. With strong focus on clean-label formulations and natural ingredients, Northern Europe remains a fast-evolving market, with opportunities in functional beverages and online retail channels.
Eastern Europe
Eastern Europe held approximately 12% of the Europe probiotics market share in 2024, with Poland and Russia emerging as the largest markets. Traditional fermented foods such as kefir and sauerkraut drive widespread awareness and cultural acceptance of probiotics. However, growth in dietary supplements and functional beverages is rising quickly, supported by increasing disposable incomes and expanding retail access. Probiotics in animal feed are also gaining traction, especially in poultry and livestock, as producers reduce antibiotic use. Although regulatory frameworks are less harmonized compared to Western Europe, rising investments from global manufacturers are fueling rapid market expansion.
Central Europe
Central Europe contributed about 5% of the market share in 2024, with Switzerland, Austria, and Hungary being key markets. Switzerland benefits from a strong base of nutraceutical companies and high consumer willingness to pay for premium supplements. Austria shows consistent demand for probiotic dairy products, while Hungary demonstrates growing interest in fortified foods and beverages. The region’s relatively smaller population size limits overall market volume, but high per-capita consumption levels support steady growth. With increasing cross-border trade and innovation-driven product launches, Central Europe is gradually strengthening its role as a niche yet profitable probiotic market in Europe.
Market Segmentations:
By Product
Probiotic Food & Beverages
Dairy Products
Cereals
Baked Food
Fermented Meat
Dry Foods
Others
Probiotic Dietary Supplements
Food Supplements
Infant Formula
Others
Animal Feed
By Ingredient
Bacteria
Lactobacillus
Bifidobacterium
Streptococcus
Others
Yeast
Saccharomyces
Others
By End User
Human Probiotics
Adult
Children
Animal Probiotics
Livestock
Poultry
Aquaculture
By Distribution Channel
Hypermarkets/Supermarkets
Pharmacies/Drugstore
Specialty Stores
Online Stores
By Geography
Western Europe
Southern Europe
Northern Europe
Eastern Europe
Central Europe
Competitive Landscape
The Europe probiotics market is highly competitive, with global leaders and regional specialists driving innovation across food, supplements, and animal nutrition. Key players such as Novozymes A/S, BioGaia, Nestlé S.A., Danone S.A., and Yakult Honsha Co., Ltd. dominate through strong product portfolios and widespread distribution networks. DSM-Firmenich, Kerry Group, Lallemand Inc., and Chr. Hansen A/S are expanding their strain development and formulation capabilities to meet rising demand for scientifically validated products. Companies like Adisseo and Probi are strengthening their positions in animal feed and dietary supplements, respectively, aligning with the shift toward preventive healthcare and antibiotic reduction. International Flavors & Fragrances Inc. enhances market reach through advanced delivery systems and encapsulation technologies, ensuring strain stability. The competitive landscape is shaped by mergers, partnerships, and R&D investments focused on expanding non-dairy probiotic applications and plant-based formats. Growing emphasis on clinical validation, regulatory compliance, and digital marketing strategies continues to define competition across Europe.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
In October 2024, Probi launched clinically-supported probiotic solution for metabolic health.
In August 2024, AB-Biotics launched probiotic solutions Gyntima Menopause (complex probiotic made of Lacotobacillus crispatus KABP™ Lactobacillus plantarum KABP™ 051 (CECT 7481), and Lactococcus lactis KABP™ 021 (CECT 7483). It helps to regulate estrogen level by reactivating it through β-glucuronidase (GUS) activity in women suffering from perimenopausal symptoms.
In August 2024, ZBiotics announced the completion of venture series A (amounting to USD 12 million) in order to support the commercialization of genetically engineered probiotics.
In February 2024, AB Biotics SA (Netherlands) expands its presence in Asia, partnering with Wonderlab for their globally marketed product, AB-LIFE. The collaboration introduces Shape100, a probiotic blend focusing on cardiometabolic health, to the Chinese market. This strategic move aims to address cholesterol-related concerns through evidence-based solutions.
In November 2023, Nestlé (Switzerland) launched N3 milk, a breakthrough in nutritional innovation. Incorporating prebiotic fibers and reduced lactose, it enriches gut health and boasts over 15% fewer calories. Tailored for diverse dietary needs, N3 supports bone health, muscle growth, and immunity.
In April 2022, Symrise, a r producer of cosmetic ingredients, launched SymFerment, a cutting-edge ingredient designed to enhance skin care with its moisturizing and smoothing properties. Developed in collaboration with Probi, a leading manufacturer of probiotics for the healthcare and food industries, SymFerment represents a significant advancement in sustainable cosmetic technology
Report Coverage
The research report offers an in-depth analysis based on Product,Ingredient, End User, Distribution Channel and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook
The Europe probiotics market will expand steadily with rising demand for preventive healthcare.
Dairy-based products will remain dominant, but non-dairy formats will gain stronger momentum.
Plant-based probiotics will see rapid adoption among vegan and lactose-intolerant consumers.
Functional beverages will become a major growth driver in wellness and sports nutrition.
Online sales and subscription models will strengthen consumer access and brand loyalty.
Innovation in encapsulation technologies will improve probiotic stability and shelf life.
Animal probiotics will expand as alternatives to antibiotics in livestock and poultry.
Regulatory clarity and clinical validation will shape consumer trust and product credibility.
Western Europe will sustain leadership, while Northern and Eastern Europe will grow faster.
Competitive intensity will increase as global and regional players expand their product portfolios.
Food and Beverages Packaging Machine Market size was valued USD 21.38 Billion in 2024 and is anticipated to reach USD 31.83 Billion by 2032, at a CAGR of 5.1% during the forecast period.
Food Technology Market size was valued USD 209.1 billion in 2024 and is anticipated to reach USD 439.83 billion by 2032, at a CAGR of 9.74% during the forecast period.
Global Probiotics market size was valued at USD 566.8 million in 2018 and increased to USD 68,971.3 million in 2024. It is anticipated to reach USD 143,112.5 million by 2032, growing at a CAGR of 9.62% during the forecast period.
Japan Probiotics market size was valued at USD 2,482.76 million in 2018 and reached USD 4,319.10 million in 2024. It is anticipated to reach USD 9,236.48 million by 2032, growing at a CAGR of 9.7% during the forecast period.
North America Probiotics Market size was valued at USD 8,835.46 million in 2018 and increased to USD 14,495.79 million in 2024. It is anticipated to reach USD 28,622.51 million by 2032, growing at a CAGR of 9.0% during the forecast period.
U.S. Probiotics market size was valued at USD 6,489.64 million in 2018 and grew to USD 10,432.83 million in 2024. It is anticipated to reach USD 20,035.75 million by 2032, at a CAGR of 8.35% during the forecast period.
Australia Probiotics market size was valued at USD 1,511.30 million in 2018 and grew to USD 2,527.53 million in 2024. It is anticipated to reach USD 5,124.14 million by 2032, at a CAGR of 9.3% during the forecast period.
The low sodium sea salt market size was valued at USD 450 million in 2024 and is anticipated to reach USD 690.61 million by 2032, at a CAGR of 5.5 % during the forecast period.
The liquor confectionery market size was valued at USD 741.7 million in 2024 and is anticipated to reach USD 1173.26 million by 2032, at a CAGR of 5.9 % during the forecast period.
The Non-Perishable Milk market was valued at USD 200.47 billion in 2024 and is projected to reach USD 298.45 billion by 2032, expanding at a CAGR of 5.1% during the forecast period.
Hygienic Easy to Clean Food Processing Equipment Market size was valued at USD 53.6 Billion in 2024 and is anticipated to reach USD 79.79 Billion by 2032, at a CAGR of 5.1% during the forecast period.
U.S. Antifreeze Proteins Market size was valued at USD 4.46 million in 2018, reached USD 8.77 million in 2024, and is anticipated to reach USD 51.74 million by 2032, growing at a CAGR of 23.18% during the forecast period.
Licence Option
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$3999
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$5999
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.
Materials Scientist (privacy requested)
The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.
